Prosecution Insights
Last updated: May 29, 2026

Examiner: LU, FRANK WEI MIN

Tech Center 1600 • Art Units: 1634 1683

This examiner grants 63% of resolved cases

Performance Statistics

63.0%
Allow Rate
+3.0% vs TC avg
758
Total Applications
+66.3%
Interview Lift
1493
Avg Prosecution Days
Based on 692 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
5.6%
§102 Novelty
34.7%
§103 Obviousness
43.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17911633 COMPOSITIONS AND METHODS OF TREATING GLIOMA Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17496742 METHODS OF GENERATING NANOARRAYS AND MICROARRAYS Final Rejection NAUTILUS SUBSIDIARY, INC.
18074369 METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS Non-Final OA CALIFORNIA INSTITUTE OF TECHNOLOGY
18249597 A SCREENING PLATFORM FOR ADAR-RECRUITING GUIDE RNAS Non-Final OA The Board of Trustees of the Leland Stanford Junior University
16588208 DIAGNOSTIC METHODS AND KITS FOR EARLY DETECTION OF OVARIAN CANCER Non-Final OA Ramot at Tel-Aviv University Ltd.
16739866 FUNCTIONAL ANALYSIS OF CANCER CELLS Final Rejection Dana-Farber Cancer Institute, Inc.
17975384 CONSECUTIVE HYBRIDIZATION FOR MULTIPLEXED ANALYSIS OF BIOLOGICAL SAMPLES Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18132298 METHODS AND COMPOSITIONS FOR LIGATION AND SAMPLE ANALYSIS Non-Final OA 10x Genomics, Inc.
18009093 METHODS FOR SPATIAL ANALYSIS USING BLOCKER OLIGONUCLEOTIDES Non-Final OA 10x Genomics, Inc.
17812075 METHODS FOR SAMPLE TRANSFER FOR IN SITU ANALYSIS Final Rejection 10x Genomics, Inc.
17871702 PROGRAMMABLE ENZYME-ASSISTED SELECTIVE EXPONENTIAL AMPLIFICATION FOR SENSITIVE DETECTION OF RARE MUTANT ALLELES Non-Final OA The Trustees of the University of Pennsylvania
17822948 MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES Non-Final OA Becton, Dickinson and Company
17207040 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ARRHYTHMIAS Non-Final OA Arizona Board of Regents on Behalf of the University of Arizona
17749858 UNIVERSAL LAMP ASSAYS FOR DETECTION OF NUCLEIC ACID TARGETS Non-Final OA Duke University
17902916 TNA-BASED PROBE FOR DETECTING AND IMAGING A TARGET miRNA IN LIVING CELLS Non-Final OA City University of Hong Kong
18800497 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS Non-Final OA Sequenom, Inc.
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION Non-Final OA KEYGENE N.V.
17865159 Set of Oligonucleotide Probes as Well as Methods and Uses Thereto Non-Final OA Roche Molecular Systems, Inc.
17930513 METHOD FOR DETECTING SENSE AND ANTISENSE STRANDS IN AN OLIGONUCLEOTIDE DUPLEX Non-Final OA Meso Scale Technologies, LLC.
17948025 METHOD FOR BIDIRECTIONAL SEQUENCING Non-Final OA OXFORD NANOPORE TECHNOLOGIES PLC
18059370 METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME Non-Final OA Sinai Health System
18015627 SYSTEMS AND METHODS FOR CELL CAPTURE, BIOMARKER DETECTION, AND CONTACT-FREE CELL LYSIS Non-Final OA Trustees of Dartmouth College
18046893 RECOMBINANT REVERSE TRANSCRIPTASE VARIANTS Non-Final OA Codexis, Inc.
16849549 METHODS AND COMPOSITIONS FOR BIOSENSING Final Rejection The University of North Carolina at Charlotte
16786647 SIGNALING CONJUGATES AND METHODS OF USE Non-Final OA VENTANA MEDICAL SYSTEMS, INC.
17905724 MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM Non-Final OA Roche Sequencing Solutions, Inc.
13703309 METHOD FOR DETERMINATION OF TARGET CELLS OR TISSUE FOR EXTRACTION OF BIOMOLECULES FROM FIXED BIOLOGICAL SAMPLES Final Rejection QIAGEN GMBH
18342759 MOLECULAR MARKERS LINKED TO MAIN QTL FOR REGULATING RESISTANCE OF RICE TO WHITEBACKED PLANTHOPPER AND APPLICATION THEREOF Non-Final OA Zhejiang Normal University
18330847 SEQUENCING BY EMERGENCE Final Rejection XGenomes Corp.
18254141 Methods Of Signal Amplification Non-Final OA Phitonex, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month